Sponsor: Incyte Corp.
Sponsor Study ID: INCA34176-357
Study Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease.
CTO #: 104037
NCT Number: NCT06585774
Phase: III
Protocol Type: Treatment
Age Group: Both
Disease Sites: Other Hematopoietic
Study Objectives: To compare the efficacy of axatilimab versus placebo in combination with corticosteroids as initial treatment for moderate or severe cGVHD. To evaluate the clinical benefit of axatilimab in combination with corticosteroids in participants with cGVHD with respect to secondary endpoints.